Skip to main content

Drugs Made In America Acquisition Corp.

DMAA
Exchange
Nasdaq
Industry
Blank Checks
SEC CIK
0002028614

No open-market purchases or sales by Drugs Made In America Acquisition Corp. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $124.9M in total; no superinvestor holds it.

Other share classesDMAARDMAAU

13F holders, Q2 2025

Institutional positions in Drugs Made In America Acquisition Corp. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
32
+9 vs. Q1 2025
Shares held
20.8M
+1.68M (+8.8%) vs. Q1 2025
Total value
$212.3M
+$46.4M (+27.9%) vs. Q1 2025
New holders
11
7 more added
Sold out
2
6 more reduced

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DMAA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2025: 32 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 24 institutionsQ2 2025: 32 institutionsQ3 2025: 37 institutionsQ4 2025: 39 institutionsQ1 2026: 39 institutionsQ2 2026: 23 institutions
Value heldQ2 2025: $212.3M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $171.3MQ2 2025: $212.3MQ3 2025: $223.4MQ4 2025: $232.1MQ1 2026: $237.3MQ2 2026: $124.9M
Institutions holding DMAA and their total value by quarter
QuarterHoldersValue
Q2 202623$124.9M
Q1 202639$237.3M
Q4 202539$232.1M
Q3 202537$223.4M
Q2 202532$212.3M
Q1 202524$171.3M
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2025

Shares, value and share of portfolio for each institution holding Drugs Made In America Acquisition Corp.; share changes are against Q1 2025.

Institutions holding DMAA in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
UBS Group AG1$100.00%+1New
Morgan Stanley109$1.11K0.00%+89+445.0%Added
Geode Capital Management, LLC45,648$465.6K0.00%+186+0.4%Added
Virtu Financial LLC46,685$476.0K0.02%+14,908+46.9%Added
Logan Stone Capital, LLC60,991$622.1K0.29%+60,991New
Bulldog Investors, LLP72,964$744.2K0.19%+72,964New
Warberg Asset Management LLC92,055$939.0K0.23%00.0%Unchanged
Verition Fund Management LLC100,000$1.02M0.01%+100,000New
Shaolin Capital Management LLC100,000$1.02M0.04%+100,000New
Clear Street LLC112,615$1.15M0.01%+112,615New
Goldman Sachs Group Inc119,686$1.22M0.00%00.0%Unchanged
Radcliffe Capital Management, L.P.126,722$1.29M0.10%+126,722New
Schonfeld Strategic Advisors LLC149,215$1.52M0.01%−50,785−25.4%Reduced
DLD Asset Management, LP188,722$1.92M0.23%−161,278−46.1%Reduced
Mangrove Partners350,000$3.57M0.38%00.0%Unchanged
CNH Partners LLC376,314$3.84M0.09%−4,000−1.1%Reduced
Whitebox Advisors LLC400,000$4.08M0.11%00.0%Unchanged
LMR Partners LLP500,000$5.10M0.08%00.0%Unchanged
Toronto Dominion Bank500,000$5.10M0.01%−1,710,100−77.4%Reduced
Atw Spac Management LLC570,000$5.81M8.90%00.0%Unchanged
Boothbay Fund Management, LLC570,000$5.81M0.18%+570,000New
Heights Capital Management, Inc650,000$6.63M2.07%+650,000New
D. E. Shaw & Co., Inc.690,000$7.04M0.01%+690,000New
Aristeia Capital LLC881,716$8.99M0.25%−18,284−2.0%Reduced
Mizuho Securities USA LLC919,787$9.29M0.20%+919,787New
Wolverine Asset Management LLC1,021,906$10.4M0.17%+418,868+69.5%Added
Westchester Capital Management, LLC1,669,000$17.0M1.00%+690,000+70.5%Added
Hudson Bay Capital Management LP1,800,000$18.4M0.12%00.0%Unchanged
Glazer Capital, LLC1,822,450$18.6M0.66%−5020.0%Reduced
Polar Asset Management Partners Inc.1,900,000$19.4M0.48%00.0%Unchanged
Vivaldi Asset Management, LLC2,242,500$22.9M1.55%+175,798+8.5%Added
Karpus Management, Inc.2,744,109$28.0M0.90%+420,075+18.1%Added
Quarry LP0$00.00%−650,000−100.0%Sold out
Crossingbridge Advisors, LLC0$00.00%−850,000−100.0%Sold out
Mizuho Securities USA LLC––––Not filed